Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission.

Autores de IIS La Fe

• Leonor Puchades Carrasco

  Autor

• Abelardo Garcia De Lorenzo Mateos

  Autor

• Antonio Pineda Lucena

  Autor

Participantes ajenos a IIS La Fe

• Lecumberri R
• Martínez-López J
• Lahuerta JJ
• Prósper F
• San-Miguel JF

Abstract

Multiple myeloma remains an incurable disease. New approaches to develop better tools for improving patient prognostication and monitoring treatment efficacy are very much needed. In this study, we aimed to evaluate the potential of metabolomics by (1)H-NMR to provide information on metabolic profiles that could be useful in the management of multiple myeloma.